These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 8105536

  • 1. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.
    Richeldi L, Sorrentino R, Saltini C.
    Science; 1993 Oct 08; 262(5131):242-4. PubMed ID: 8105536
    [Abstract] [Full Text] [Related]

  • 2. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
    Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS.
    J Immunol; 2003 Dec 15; 171(12):6910-8. PubMed ID: 14662898
    [Abstract] [Full Text] [Related]

  • 3. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.
    Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP.
    J Immunol; 2005 Nov 15; 175(10):7029-37. PubMed ID: 16272364
    [Abstract] [Full Text] [Related]

  • 4. To Be2+ or not to Be2+: immunogenetics and occupational exposure.
    Newman LS.
    Science; 1993 Oct 08; 262(5131):197-8. PubMed ID: 8105535
    [No Abstract] [Full Text] [Related]

  • 5. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.
    Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL.
    Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12717-22. PubMed ID: 11050177
    [Abstract] [Full Text] [Related]

  • 6. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
    McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A.
    Am J Ind Med; 2004 Aug 07; 46(2):95-103. PubMed ID: 15273960
    [Abstract] [Full Text] [Related]

  • 7. Genetic determinants of sensitivity to beryllium in mice.
    Tarantino-Hutchison LM, Sorrentino C, Nadas A, Zhu Y, Rubin EM, Tinkle SS, Weston A, Gordon T.
    J Immunotoxicol; 2009 Jun 07; 6(2):130-5. PubMed ID: 19589099
    [Abstract] [Full Text] [Related]

  • 8. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
    Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL.
    J Immunol; 1999 Aug 01; 163(3):1647-53. PubMed ID: 10415070
    [Abstract] [Full Text] [Related]

  • 9. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.
    Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R.
    J Immunol; 2001 Mar 01; 166(5):3549-55. PubMed ID: 11207315
    [Abstract] [Full Text] [Related]

  • 10. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
    Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA.
    Am J Respir Crit Care Med; 2011 Jun 15; 183(12):1680-8. PubMed ID: 21471109
    [Abstract] [Full Text] [Related]

  • 11. Linking genetic susceptibility and T cell activation in beryllium-induced disease.
    Falta MT, Bowerman NA, Dai S, Kappler JW, Fontenot AP.
    Proc Am Thorac Soc; 2010 May 15; 7(2):126-9. PubMed ID: 20427584
    [Abstract] [Full Text] [Related]

  • 12. Beryllium sensitivity is linked to HLA-DP genotype.
    Wang Z, Farris GM, Newman LS, Shou Y, Maier LA, Smith HN, Marrone BL.
    Toxicology; 2001 Aug 13; 165(1):27-38. PubMed ID: 11551429
    [Abstract] [Full Text] [Related]

  • 13. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
    Gaede KI, Amicosante M, Schürmann M, Fireman E, Saltini C, Müller-Quernheim J.
    J Mol Med (Berl); 2005 May 13; 83(5):397-405. PubMed ID: 15750822
    [Abstract] [Full Text] [Related]

  • 14. Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.
    Silveira LJ, McCanlies EC, Fingerlin TE, Van Dyke MV, Mroz MM, Strand M, Fontenot AP, Bowerman N, Dabelea DM, Schuler CR, Weston A, Maier LA.
    J Immunol; 2012 Oct 15; 189(8):4014-23. PubMed ID: 22972925
    [Abstract] [Full Text] [Related]

  • 15. HLA-DPB1 and chronic beryllium disease: a HuGE review.
    McCanlies EC, Kreiss K, Andrew M, Weston A.
    Am J Epidemiol; 2003 Mar 01; 157(5):388-98. PubMed ID: 12615603
    [Abstract] [Full Text] [Related]

  • 16. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
    Rosenman KD, Rossman M, Hertzberg V, Reilly MJ, Rice C, Kanterakis E, Monos D.
    Occup Environ Med; 2011 Jul 01; 68(7):487-93. PubMed ID: 21186201
    [Abstract] [Full Text] [Related]

  • 17. T cell recognition in chronic beryllium disease.
    Amicosante M, Fontenot AP.
    Clin Immunol; 2006 Nov 01; 121(2):134-43. PubMed ID: 16697706
    [Abstract] [Full Text] [Related]

  • 18. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.
    Sato H, Spagnolo P, Silveira L, Welsh KI, du Bois RM, Newman LS, Maier LA.
    Tissue Antigens; 2007 Dec 01; 70(6):480-6. PubMed ID: 17927685
    [Abstract] [Full Text] [Related]

  • 19. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
    McCleskey TM, Buchner V, Field RW, Scott BL.
    Rev Environ Health; 2009 Dec 01; 24(2):75-115. PubMed ID: 19658317
    [Abstract] [Full Text] [Related]

  • 20. Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity.
    Rogliani P, Amicosante M, Berretta F, Dotti C, Bocchino M, O'Donnell KM, Saltini C.
    Int J Immunopathol Pharmacol; 2004 Dec 01; 17(2 Suppl):3-10. PubMed ID: 15345185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.